These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 24496449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
    Filmus J, Capurro M.
    FEBS J; 2013 May; 280(10):2471-6. PubMed ID: 23305321
    [Abstract] [Full Text] [Related]

  • 3. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
    Capurro MI, Xiang YY, Lobe C, Filmus J.
    Cancer Res; 2005 Jul 15; 65(14):6245-54. PubMed ID: 16024626
    [Abstract] [Full Text] [Related]

  • 4. Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.
    Capurro MI, Shi W, Sandal S, Filmus J.
    J Biol Chem; 2005 Dec 16; 280(50):41201-6. PubMed ID: 16227623
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface.
    Traister A, Shi W, Filmus J.
    Biochem J; 2008 Mar 15; 410(3):503-11. PubMed ID: 17967162
    [Abstract] [Full Text] [Related]

  • 8. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma.
    Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y.
    World J Gastroenterol; 2010 Jul 28; 16(28):3521-8. PubMed ID: 20653060
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH, Cooper K.
    Adv Anat Pathol; 2009 Mar 28; 16(2):125-9. PubMed ID: 19550373
    [Abstract] [Full Text] [Related]

  • 11. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells.
    Saad A, Liet B, Joucla G, Santarelli X, Charpentier J, Claverol S, Grosset CF, Trézéguet V.
    Biochemistry; 2018 Feb 20; 57(7):1201-1211. PubMed ID: 29345911
    [Abstract] [Full Text] [Related]

  • 12. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.
    Int J Cancer; 2003 Feb 10; 103(4):455-65. PubMed ID: 12478660
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R.
    Int J Mol Med; 2011 Oct 10; 28(4):497-503. PubMed ID: 21617840
    [Abstract] [Full Text] [Related]

  • 14. Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.
    Gao W, Kim H, Ho M.
    PLoS One; 2015 Oct 10; 10(9):e0137664. PubMed ID: 26332121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.
    Montalbano M, Rastellini C, McGuire JT, Prajapati J, Shirafkan A, Vento R, Cicalese L.
    Cell Oncol (Dordr); 2018 Apr 10; 41(2):169-184. PubMed ID: 29204978
    [Abstract] [Full Text] [Related]

  • 17. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.
    Lai JP, Oseini AM, Moser CD, Yu C, Elsawa SF, Hu C, Nakamura I, Han T, Aderca I, Isomoto H, Garrity-Park MM, Shire AM, Li J, Sanderson SO, Adjei AA, Fernandez-Zapico ME, Roberts LR.
    Hepatology; 2010 Nov 10; 52(5):1680-9. PubMed ID: 20725905
    [Abstract] [Full Text] [Related]

  • 18. Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling.
    Capurro M, Shi W, Izumikawa T, Kitagawa H, Filmus J.
    J Biol Chem; 2015 Mar 20; 290(12):7576-85. PubMed ID: 25653284
    [Abstract] [Full Text] [Related]

  • 19. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
    Maurel M, Jalvy S, Ladeiro Y, Combe C, Vachet L, Sagliocco F, Bioulac-Sage P, Pitard V, Jacquemin-Sablon H, Zucman-Rossi J, Laloo B, Grosset CF.
    Hepatology; 2013 Jan 20; 57(1):195-204. PubMed ID: 22865282
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
    Zaghloul RA, El-Shishtawy MM, El Galil KH, Ebrahim MA, Metwaly AA, Al-Gayyar MM.
    Eur J Pharmacol; 2015 Jan 05; 746():353-62. PubMed ID: 25449037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.